Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Xenon Pharmaceuticals Inc. Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update May 09, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024 May 08, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference May 07, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update May 02, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting April 16, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference April 10, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference April 04, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days March 12, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024 March 05, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update February 29, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update February 22, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024 January 08, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares December 04, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023) December 02, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Announces Pricing of Upsized $300.0 Million Public Offering November 29, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Announces Proposed Public Offering November 29, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Announces Topline Results from Phase 2 Proof-of-Concept X-NOVA Clinical Trial of XEN1101 in Major Depressive Disorder (MDD) November 27, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Provides Update on Partnered Program with Neurocrine Biosciences November 09, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update November 08, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Corporate Update November 01, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Announces Publication of Results from XEN1101 Phase 2b “X-TOLE” Clinical Trial in Peer-Reviewed Journal Article in JAMA Neurology October 09, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals to Present at Jefferies Inaugural Biotech CNS/Neuro Summit October 06, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals to Present at TD Cowen’s 3rd Annual Novel Mechanisms in Neuropsychiatry Summit September 14, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Announces Upcoming Investor Webinar with Leading Key Opinion Leaders to Discuss XEN1101 and Major Depressive Disorder September 12, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Showcases XEN1101 Epilepsy Program at 35th International Epilepsy Congress September 04, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals to Present at the Wells Fargo 2023 Healthcare Conference August 31, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update August 09, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Expands Leadership on its Board of Directors with Appointments of Gillian M. Cannon and Justin Gover August 08, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Second Quarter 2023 Financial Results and Provide Corporate Update August 02, 2023 From Xenon Pharmaceuticals Inc. Via GlobeNewswire Tickers XENE Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.